Peanut vs Other Food Oral Immunotherapy: Trends from an Outpatient Allergy Clinic in Boise, ID

被引：0
|
作者：
Monje, Kahlil [1 ]
Sadegh, Mojtaba [2 ]
Talreja, Neetu [1 ]
机构：
[1] Allergy Grp, Boise, ID USA
[2] Boise State Univ, Boise, ID USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
378
引用
收藏
页码：AB122 / AB122
页数：1
相关论文
共 41 条
  • [31] RETHINKING PREDICTIVE VALUES OF IGE AND SKIN PRICK TESTS: INSIGHTS FROM ORAL FOOD CHALLENGES IN CHILDREN WITH PEANUT ALLERGY DIAGNOSES
    Launius, Christopher
    Kaul, Bridgette
    Freigeh, George
    O'Shea, Kelly
    Schuler, Charles
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 168 - 168
  • [32] Home epinephrine-treated reactions in food allergy oral immunotherapy Lessons from the coronavirus disease 2019 lockdown
    Nachshon, Liat
    Goldberg, Michael R.
    Levy, Michael B.
    Epstein-Rigbi, Naama
    Koren, Yael
    Elizur, Arnon
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (04) : 451 - +
  • [33] Longer-Term Safety and Efficacy Measures of AR101 Oral Immunotherapy for Peanut Allergy: Results from a Phase 3 Follow-On Study
    Carr, Tara F.
    Shreffler, Wayne G.
    Griffin, Noelle M.
    Rosen, Karin
    Zawadzki, Rezi
    Matthews, John
    Adelman, Daniel C.
    Jones, Stacie M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB256 - AB256
  • [34] Longer-term safety and efficacy measures of AR101 oral immunotherapy for peanut allergy: Results from a phase 3 follow-on study
    Sher, Ellen
    Shreffler, Wayne G.
    Griffin, Noelle M.
    Zawadzki, Rezi
    Jones, Stacie M.
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 357 - 358
  • [35] Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study (vol 9, pg 1879, 2021)
    Vickery, Brian P.
    Vereda, Andrea
    Nilsson, Caroline
    du Toit, George
    Shref, Wayne G.
    Burks, A. Wesley
    Jones, Stacie M.
    Fernandez-Rivas, Montserrat
    Blumchen, Katharina
    Hourihane, Jonathan O'B.
    Beyer, Kirsten
    Anagnostou, Aikaterini
    Assa'ad, Amal H.
    Ben-Shoshan, Moshe
    Bird, J. Andrew
    Carr, Tara F.
    Ciaccio, Warner
    Casale, Thomas B.
    Chong, Hey Jin
    Ciaccio, Christine E.
    Dorsey, Morna J.
    Fineman, Stanley M.
    Fritz, Stephen B.
    Greiner, Alexander N.
    Greos, Leon S.
    Hampel, Frank C., Jr.
    Ibanez, Maria Dolores
    Jeong, David K.
    Johnston, Douglas T.
    Kachru, Rita
    Kim, Edwin H.
    Lanser, Bruce J.
    Leonard, Stephanie A.
    Maier, Mary C.
    Mans, Lyndon E.
    Muraro, Antonella
    Ohayon, Jason A.
    Elberink, Joanna N. G. Oude
    Petroni, Daniel H.
    Pongracic, Jacqueline A.
    Portnoy, Jay M.
    Rachid, Rima
    Rupp, Ned T.
    Sanders, Georgiana M.
    Sharma, Hemant P.
    Sharma, Vibha
    Sher, Ellen R.
    Sher, Lawrence
    Sindher, Sayantani B.
    Siri, Dareen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 647 - 650
  • [36] Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?
    Eiwegger, Thomas
    Anagnostou, Katherine
    Arasi, Stefania
    Begin, Philippe
    Ben-Shoshan, Moshe
    Beyer, Kirsten
    Blumchen, Katharina
    Brough, Helen
    Caubet, Jean-Christoph
    Chan, Edmond S.
    Chen, Meng
    Chinthrajah, Sharon
    Davis, Carla M.
    Roches, Anne Des
    Du Toit, George
    Elizur, Arnon
    Galli, Stephen J.
    Haland, Geir
    Hoffmann-Sommergruber, Karin
    Kim, Harold
    Leung, Donald Y. M.
    Long, Andrew
    Muraro, Antonella
    Nurmatov, Ulugbek B.
    Pajno, Giovanni B.
    Sampath, Vanitha
    Saxena, Jamie
    Sindher, Sayantani
    Upton, Julia
    Worm, Margitta
    Nadeau, Kari C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (04) : 1153 - 1156
  • [37] Impact of Peanut Allergy on Quality of Life: Baseline Results from PALISADE, a Phase 3, Double-Blind, Placebo-Controlled Trial for AR101 Oral Immunotherapy
    Wang, Julie
    Johnston, Douglas T.
    Lieberman, Jay A.
    Birchwood, Christine
    Acaster, Sarah
    de Vries, Jane
    Vereda, Andrea
    Zawadzki, Rezi
    Hass, Steve
    Zawadzki, Nadine
    DunnGalvin, Audrey
    Dubois, Anthony E. J.
    Rosen, Karin
    Hourihane, Jonathan O'B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB155 - AB155
  • [38] Long-Lasting Egg Consumption in Egg Allergic Children Treated with Oral Immunotherapy (OIT): Follow-up from the Consortium of Food Allergy Research (CoFAR) Study
    Jones, Stacie M.
    Burks, A. Wesley
    Wood, Robert A.
    Fleischer, David Mark
    Sicherer, Scott H.
    Henning, Alice
    Lindblad, Robert
    Dawson, Peter
    Vickery, Brian P.
    Keet, Corinne
    Liu, Andrew H.
    Scurlock, Amy M.
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB403 - AB403
  • [39] \ Egg Oral Immunotherapy (OIT) Induces Clinical Desensitization in a Double-Blind, Placebo-Controlled (DBPC) Trial in Egg Allergic Children from the Consortium of Food Allergy Research (CoFAR)
    Jones, S. M.
    Fleischer, D. M.
    Sicherer, S. H.
    Wood, R. A.
    Lindblad, R.
    Stablein, D.
    Liu, A. H.
    Shreffler, W.
    Leung, D. Y. M.
    Sampson, H. A.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB357 - AB357
  • [40] Immune responses in 496 patients aged 4-17 years with peanut allergy treated with oral immunotherapy using AR101: Results from a phase 3, randomized, double-blind, placebo-controlled trial (palisade)
    Beyer, K.
    Burks, A. W.
    Casale, T. B.
    Du Toit, G.
    Hourihane, J. O.
    Jones, S. M.
    Shreffler, W. G.
    Marcantonio, A.
    Vereda, A.
    Vickery, B. P.
    Rosen, K.
    Zawadzki, R.
    Adelman, D. C.
    ALLERGY, 2018, 73 : 338 - 339
12345